Cannabis and cancer: unveiling the potential of a green ally in breast, colorectal, and prostate cancer | Journal of Cannabis Research
Ahmed L. Cytotoxicity of Non-Psychoactive Cannabinoids with an Emphasis on Cannabidiol and Ovarian Cancer. Canada: University of Toronto; 2022.
Ammar-Shehada W, Abusaman K, Bracke P. Perceived support, social and marital challenges in the lives of breast cancer survivors after illness: a self-administered cross-sectional survey. Front Sociol. 2023;8:1227529.
Araújo M, Almeida MB, Araújo LLN. The cannabinoids mechanism of action: an overview. BrJP. 2023.
Asadi M, Taghizadeh S, Kaviani E, Vakili O, Taheri-Anganeh M, Tahamtan M, et al. Caspase-3: structure, function, and biotechnological aspects. Biotechnol Appl Biochem. 2022;69(4):1633–45.
Aviello G, Romano B, Borrelli F, Capasso R, Gallo L, Piscitelli F, et al. Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer. J Mol Med. 2012;90:925–34.
Bar-Lev Schleider L, Mechoulam R, Sikorin I, Naftali T, Novack V. Adherence, safety, and effectiveness of medical cannabis and epidemiological characteristics of the patient population: a prospective study. Front Med. 2022;9:827849.
Bennett JL, Jackson BN, Miller RJ, Tsui H, Martin-Caraballo M. IL-6 evoked biochemical changes in prostate cancer cells. Cytokine. 2023;161:156079.
Bereketoğlu C. Delivery of medicinal cannabis. 2020.
Bimonte S, Palma G, Cascella M, Cuomo A. Phytocannabinoids in Triple Negative Breast Cancer Treatment: Current Knowledge and Future Insights. Anticancer Research. 2023;43(3):993–1000.
Boissoneault J, Stennett-Blackmon B, Gilmour C, Blaes S. Neural and psychosocial mechanisms underlying alcohol use and pain interactions: overview of current evidence and future directions. Curr Addict Rep. 2023;10:1–13.
Brust CA, Swanson MA, Bohn LM. Structural and functional insights into the G protein-coupled receptors: CB1 and CB2. Biochem Soc Trans. 2023;51(4):1533–43.
Bubendorf L, Schöpfer A, Wagner U, Sauter G, Moch H, Willi N, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000;31(5):578–83.
Caffarel MM, Andradas C, Mira E, Pérez-Gómez E, Cerutti C, Moreno-Bueno G, et al. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. Mol Cancer. 2010;9(1):1–11.
Caffarel MM, Andradas C, Pérez-Gómez E, Guzmán M, Sánchez C. Cannabinoids: a new hope for breast cancer therapy? Cancer Treat Rev. 2012;38(7):911–8.
Carr C, Vertelney H, Fronk J, Trieu S. Dronabinol for the treatment of paraneoplastic night sweats in cancer patients: a report of five cases. J Palliat Med. 2019;22(10):1221–3.
Cejas P, Lopez-Gomez M, Aguayo C, Madero R, de Castro Carpeno J, Belda-Iniesta C, et al. KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis. PloS one. 2009;4(12):e8199.
Cherkasova V, Kovalchuk O, Kovalchuk I. Cannabinoids and endocannabinoid system changes in intestinal inflammation and colorectal cancer. Cancers. 2021;13(17):4353.
Coelho MP, Duarte P, Calado M, Almeida AJ, Reis CP, Gaspar MM. The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential. Life Sci. 2023;329:121838.
Cottet V, Jooste V, Fournel I, Bouvier A-M, Faivre J, Bonithon-Kopp C. Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study. Gut. 2012;61(8):1180–6.
Custódio N, Savisaar R, Carvalho C, Bak-Gordon P, Ribeiro MI, Tavares J, et al. Expression Profiling in Ovarian Cancer Reveals Coordinated Regulation of BRCA1/2 and Homologous Recombination Genes. Biomed. 2022;10(2):199.
Cuzick J, Thorat MA, Andriole G, Brawley OW, Brown PH, Culig Z, et al. Prevention and early detection of prostate cancer. Lancet Oncol. 2014;15(11):e484–92.
Czene K, Lichtenstein P, Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family‐cancer database. Int J Cancer. 2002;99(2):260–6.
Dasari S, Njiki S, Mbemi A, Yedjou CG, Tchounwou PB. Pharmacological effects of cisplatin combination with natural products in cancer chemotherapy. Int J Mol Sci. 2022;23(3):1532.
Dell’Atti L, Aguiari G. The role of genetic polymorphisms in the diagnosis and management of prostate cancer: an update. Anticancer Res. 2023;43(1):317–22.
Diernberger K, Clausen E, Murray G, Wee B, Kaasa S, Hall P, et al. Cancer pain assessment and management: does an institutional approach individualise and reduce cost of care? BMJ Support Palliat Care. 2023;13:e1258–64.
Dillekås H, Rogers MS, Straume O. Are 90% of deaths from cancer caused by metastases? Cancer Med. 2019;8(12):5574–6.
de Fátima Dos Santos Sampaio M, de Paiva YB, Sampaio TB, Pereira MG, Coimbra NC. Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson’s disease and in comorbidity with psychiatric disorders. Basic Clin Pharmacol Toxicol. 2024;134(5):574–601.
Dupoiron D, Duarte R, Carvajal G, Aubrun F, Eldabe S. Rationale and recent advances in targeted drug delivery for cancer pain: is it time to change the paradigm? Pain physician. 2022;25(3):E414–25.
Feng H, Lane KA, Roumeliotis TI, Jeggo PA, Somaiah N, Choudhary JS, et al. PBAF loss leads to DNA damage-induced inflammatory signaling through defective G2/M checkpoint maintenance. Genes Devel. 2022;36(13–14):790–806.
Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–53.
Fernanda S, Valentina D, Caterina C, Andrea C. Functional TRPA1 Channels Regulate CD56dimCD16+ NK Cell Cytotoxicity against Tumor Cells. Int J Mol Sci. 2023;24(19):14736.
Friedman E, Kotsopoulos J, Lubinski J, Lynch HT, Ghadirian P, Neuhausen SL, et al. Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers. Breast Cancer Res. 2006;8:1–7.
Furtney I, Bradley R, Kabuka MR. Patient Graph Deep Learning to Predict Breast Cancer Molecular Subtype. IEEE/ACM Trans Comput Biol Bioinform. 2023;20(5):3117–27.
Gaoni Y, Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc. 1964;86(8):1646–7.
Garber JJ, Chung DC. Polyps of the Colon and Rectum. Yamada’s Textbook of Gastroenterology. 2022:1447-63.
Gorzo A, Havași A, Spînu Ș, Oprea A, Burz C, Sur D. Practical Considerations for the Use of Cannabis in Cancer Pain Management—What a Medical Oncologist Should Know. Journal of Clinical Medicine. 2022;11(17):5036.
Grierson GA. The hemp plant in Sanskrit and Hindi literature. Indian Antiquary. 1894;23:260–2.
Hammond D, Goodman S, Wadsworth E, Rynard V, Boudreau C, Hall W. Evaluating the impacts of cannabis legalization: the International Cannabis Policy Study. Int J Drug Policy. 2020;77:102698.
Han Y, Dong Q, Peng J, Li B, Ma C. Laminar Distribution of Cannabinoid Receptor 1 in the Prefrontal Cortex of Nonhuman Primates. Mol Neurobiol. 2023.
Hanuš LO, Meyer SM, Muñoz E, Taglialatela-Scafati O, Appendino G. Phytocannabinoids: a unified critical inventory. Nat Product Rep. 2016;33(12):1357–92.
Harada M, Iida M-i, Yamaguchi M, Shida K Analysis of bone metastasis of prostatic adenocarcinoma in 137 autopsy cases. Prostate Cancer and Bone Metastasis. 1992:173-82.
Hirashima T, Hino N, Aoki K, Matsuda M. Stretching the limits of extracellular signal-related kinase (ERK) signaling—Cell mechanosensing to ERK activation. Curr Opin Cell Biol. 2023;84:102217.
Honarmand M, Namazi F, Mohammadi A, Nazifi S. Can cannabidiol inhibit angiogenesis in colon cancer? Comparative Clinical Pathology. 2019;28:165–72.
Hossain MS, Karuniawati H, Jairoun AA, Urbi Z, Ooi DJ, John A, et al. Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies. Cancers. 2022;14(7):1732.
Hsieh C-H, Jian C-Z, Lin L-I, Low G-S, Ou P-Y, Hsu C, et al. Potential role of CXCL13/CXCR5 signaling in immune checkpoint inhibitor treatment in cancer. Cancers. 2022;14(2):294.
Ingleby FC, Woods LM, Atherton IM, Baker M, Elliss-Brookes L, Belot A. An investigation of cancer survival inequalities associated with individual-level socio-economic status, area-level deprivation, and contextual effects, in a cancer patient cohort in England and Wales. BMC Public Health. 2022;22:1–12.
Jeong S, Kim BG, Kim DY, Kim BR, Kim JL, Park SH, et al. Cannabidiol overcomes oxaliplatin resistance by enhancing NOS3-and SOD2-induced autophagy in human colorectal cancer cells. Cancers. 2019;11(6):781.
Jeong S, Yun HK, Jeong YA, Jo MJ, Kang SH, Kim JL, et al. Cannabidiol-induced apoptosis is mediated by activation of Noxa in human colorectal cancer cells. Cancer letters. 2019;447:12–23.
Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012;10(6):639–45.
Kadys A, Gremke N, Schnetter L, Kostev K, Kalder M. Intercontinental comparison of women with breast cancer treated by oncologists in Europe, Asia, and Latin America: a retrospective study of 99,571 patients. J Cancer Res Clin Oncol. 2023;149:1–8.
Kennecke H, Yerushalmi R, Woods R, Cheang MCU, Voduc D, Speers CH, et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010;28(20):3271–7.
Khunluck T, Lertsuwan K, Chutoe C, Sooksawanwit S, Inson I, Teerapornpuntakit J, et al. Activation of cannabinoid receptors in breast cancer cells improves osteoblast viability in cancer-bone interaction model while reducing breast cancer cell survival and migration. Sci Rep. 2022;12(1):7398.
Kosgodage US, Mould R, Henley AB, Nunn AV, Guy GW, Thomas EL, et al. Cannabidiol (CBD) is a novel inhibitor for exosome and microvesicle (EMV) release in cancer. Front Pharmacol. 2018;9:889.
Kwee CM, Leen NA, Van der Kamp RC, Van Lissa CJ, Cath DC, Groenink L, et al. Anxiolytic effects of endocannabinoid enhancing compounds: A systematic review and meta-analysis. Eur Neuropsychopharmacol. 2023;72:79–94.
Lasorsa F, di Meo NA, Rutigliano M, Ferro M, Terracciano D, Tataru OS, et al. Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer. Int J Mol Sci. 2023;24(2):910.
Lee H-S, Tamia G, Song H-J, Amarakoon D, Wei C-I, Lee S-H. Cannabidiol exerts anti-proliferative activity via a cannabinoid receptor 2-dependent mechanism in human colorectal cancer cells. Int Immunopharmacol. 2022;108:108865.
Li P, Lin Q, Sun S, Yang N, Xia Y, Cao S, et al. Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism. Cell Death Dis. 2022;13(9):808.
Liguori GL, Kralj-Iglič V. Pathological and Therapeutic Significance of Tumor-Derived Extracellular Vesicles in Cancer Cell Migration and Metastasis. Cancers. 2023;15(18):4425.
Lin Y-S, Huang W-H, Hsu K-F, Tang M-J, Chiu W-T. Reversion of chemoresistance by endocannabinoid-induced ER stress and autophagy activation in ovarian cancer. Am J Cancer Res. 2023;13(9):4163.
Liu Y-J, Wang C. A review of the regulatory mechanisms of extracellular vesicles-mediated intercellular communication. Cell Communication and Signaling. 2023;21(1):1–12.
Lyons D. Regulators of Mast Cell Activation: University of Northern Colorado; Dissertations [Internet]. 2023:960. https://digscholarship.unco.edu/dissertations/960.
Mahmoud AM, Kostrzewa M, Marolda V, Cerasuolo M, Maccarinelli F, Coltrini D, et al. Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer. Pharmacol Res. 2023;189:106683.
Maldonado Ortiz YI. Extreme environments promote cancerous behavior in healthy cells. 2022.
Markozannes G, Tzoulaki I, Karli D, Evangelou E, Ntzani E, Gunter MJ, et al. Diet, body size, physical activity and risk of prostate cancer: An umbrella review of the evidence. Eur J Cancer. 2016;69:61–9.
Martínez-Aguilar LM, Ibarra-Sánchez A, Guerrero-Morán DJ, Macías-Silva M, Muñoz-Bello JO, Padilla A, et al. Lysophosphatidylinositol Promotes Chemotaxis and Cytokine Synthesis in Mast Cells with Differential Participation of GPR55 and CB2 Receptors. Int J Mol Sci. 2023;24(7):6316.
Mechoulam R, Shvo Y. Hashish—I: the structure of cannabidiol. Tetrahedron. 1963;19(12):2073–8.
Morales P, Guerrero-Alba R, Marichal-Cancino BA. Linking the G-protein-coupled receptor 55 (GPR55) to the cannabinoid receptors (CB1 and CB2): A new narrative. Cannabis Use, Neurobiology, Psychology, and Treatment: Elsevier; 2023:395-406.
Morell C, Bort A, Vara D, Ramos-Torres A, Rodríguez-Henche N, Díaz-Laviada I. The cannabinoid WIN 55,212–2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells. Prostate Cancer Prostatic Dis. 2016;19(3):248–57.
Mousa A, Petrovic M, Fleshner NE. Prevalence and predictors of cannabis use among men receiving androgen-deprivation therapy for advanced prostate cancer. Can Urological Assoc J. 2020;14(1):E20.
Nduma BN, Mofor KA, Tatang J, Ekhator C, Ambe S, Fonkem E, et al. The Use of Cannabinoids in the Treatment of Inflammatory Bowel Disease (IBD): A Review of the Literature. Cureus. 2023;15(3):e36148.
O’Dowd PD, Sutcliffe DF, Griffith DM. Oxaliplatin and its derivatives–An overview. Coord Chem Rev. 2023;497:215439.
Oliveira HA, Somvanshi RK, Kumar U. Comparative changes in breast cancer cell proliferation and signalling following somatostatin and cannabidiol treatment. Biochem Biophys Res Commun. 2023;643:30–8.
Pak S, Jung K-W, Park E-H, Ko YH, Won Y-J, Joung JY. Incidence and mortality projections for major cancers among Korean men until 2034, with a focus on prostate cancer. Invest Clin Urology. 2022;63(2):175.
Patthy Á, Hanics J, Zachar G, Kovács GG, Harkany T, Alpár A. Regional redistribution of CB1 cannabinoid receptors in human foetal brains with Down’s syndrome and their functional modifications in Ts65Dn+/+ mice. Neuropathol Appl Neurobiol. 2023;49(1):e12887.
Pawasarat IM, Schultz EM, Frisby JC, Mehta S, Angelo MA, Hardy SS, et al. The efficacy of medical marijuana in the treatment of cancer-related pain. Journal of palliative medicine. 2020;23(6):809–16.
Pederzoli F, Raffo M, Pakula H, Ravera F, Nuzzo PV, Loda M. Stromal cells in prostate cancer pathobiology: friends or foes? Br J Cancer. 2023;128(6):930–9.
Pennant NM, Hinton CV. The evolution of cannabinoid receptors in cancer. WIREs Mech Dis. 2023;15:e1602.
Perera PK, Diddeniya JID, editors. In-vitro and in-vivo supportive research on medicinal properties of Cannabis sativa: a comprehensive review. 2022.
Pietrovito L, Iozzo M, Bacci M, Giannoni E, Chiarugi P. Treatment with cannabinoids as a promising approach for impairing fibroblast activation and prostate cancer progression. Int J Mol Sci. 2020;21(3):787.
Praphasawat R, Klajing W, Palipoch S, Wimuttiyanon J, Wutti J, Saypeark N, et al. Cancer Signaling Pathway and Anti-Cancer Mechanism of Cannabidiol. J Med Assoc Thai. 2023;106(2):219–27.
Prateeksha P, Sharma VK, Singh SM, Sharma M, Diwan D, Hesham AE-L, et al. Tetrahydrocannabinols: potential cannabimimetic agents for cancer therapy. Cancer Metastasis Rev. 2023:1-23.
Pulgar VM, Howlett AC, Eldeeb K. WIN55212-2 Modulates Intracellular Calcium via CB1 Receptor-Dependent and Independent Mechanisms in Neuroblastoma Cells. Cells. 2022;11(19):2947.
Ramsay S, Spencer NJ, Zagorodnyuk V. Endocannabinoids, anandamide and 2-AG, regulate mechanosensitivity of mucosal afferents in the Guinea pig bladder. Eur J Pharmacol. 2023;945:175624.
Rasheed SAK, Subramanyan LV, Lim WK, Udayappan UK, Wang M, Casey PJ. The emerging roles of Gα12/13 proteins on the hallmarks of cancer in solid tumors. Oncogene. 2022;41(2):147–58.
Reddy D, van Son M, Peters M, Bertoncelli Tanaka M, Dudderidge T, Cullen E, et al. Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis. J Med Econ. 2023;26(1):1099–107.
Sá SS, Melo-Alvim C, Reis-Pina P. Effects of cannabinoids on pain control, quality of life and opioid-sparing in cancer patients: systematic review. BrJP. 2023;6:320–9.
Sahu A, Raza K, Pradhan D, Jain AK, Verma S. Cyclooxygenase-2 as a therapeutic target against human breast cancer: A comprehensive review. WIREs Mech Dis. 2023;15(3):e1596.
Schoen RE, Razzak A, Kelly JY, Berndt SI, Firl K, Riley TL, et al. Incidence and mortality of colorectal cancer in individuals with a family history of colorectal cancer. Gastroenterol. 2015;149(6):1438–45 e1.
Selvaraj NB, Swaroop AK, Mariappan E, Natarajan J, Thangavelu P, Selvaraj J. Effect of Calcitriol in Inhibiting the Cancer Cell Growth and Promoting Apoptosis in ErbB2-positive Breast Cancer Cells. Anticancer Agents Med Chem. 2023;23(18):2056–71.
Shah SA, Gupta AS, Kumar P. Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management. J Cancer Res Ther. 2021;17(1):1–9.
Simard M, Archambault A-S, Lavoie J-PC, Dumais É, Di Marzo V, Flamand N. Biosynthesis and metabolism of endocannabinoids and their congeners from the monoacylglycerol and N-acyl-ethanolamine families. Biochemical Pharmacol. 2022;205:115261.
Singh K, Nassar N, Bachari A, Schanknecht E, Telukutla S, Zomer R, et al. The pathophysiology and the therapeutic potential of cannabinoids in prostate cancer. Cancers. 2021;13(16):4107.
Smith-Warner SA, Spiegelman D, Yaun S-S, Van Den Brandt PA, Folsom AR, Goldbohm RA, et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. Jama. 1998;279(7):535–40.
Sun V, Grant M, McMullen CK, Altschuler A, Mohler MJ, Hornbrook MC, et al. From diagnosis through survivorship: health-care experiences of colorectal cancer survivors with ostomies. Support Care Cancer. 2014;22:1563–70.
Suttithumsatid W, Sukketsiri W, Panichayupakaranant P. Cannabinoids and standardized cannabis extracts inhibit migration, invasion, and induce apoptosis in MCF-7 cells through FAK/MAPK/Akt/NF-κB signaling. Toxicol Vitro. 2023;93:105667.
Taffoni C, Marines J, Chamma H, Guha S, Saccas M, Bouzid A, et al. DNA damage repair kinase DNA-PK and cGAS synergize to induce cancer-related inflammation in glioblastoma. The EMBO Journal. 2023;42(7):e111961.
Tamimi RM, Spiegelman D, Smith-Warner SA, Wang M, Pazaris M, Willett WC, et al. Population attributable risk of modifiable and nonmodifiable breast cancer risk factors in postmenopausal breast cancer. Am J Epidemiol. 2016;184(12):884–93.
Todd A. Marihuana. America’s New Drug Problem: Nature Publishing Group UK London; 1939.
Tomko AM, Whynot EG, O’Leary LF, Dupré DJ. Anti-cancer potential of cannabis terpenes in a taxol-resistant model of breast cancer. Can J Physiol Pharmacol. 2022;100(8):806–17.
Touw M. The religious and medicinal uses of Cannabis in China, India and Tibet. J Psychoactive Drugs. 1981;13(1):23–34.
Tundidor I, Seijo-Vila M, Blasco-Benito S, Rubert-Hernández M, Adámez S, Andradas C, et al. Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer. Nat Commun. 2023;14(1):3130.
Van der Pool A, Damhuis R, Ijzermans J, de Wilt J, Eggermont A, Kranse R, et al. Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series. Colorectal Dis. 2012;14(1):56–61.
Vatrella A, Maglio A, Pelaia C, Pelaia G, Vitale C. Pharmacotherapeutic strategies for critical asthma syndrome: a look at the state of the art. Expert Opin Pharmacother. 2020;21(12):1505–15.
Voicu V, Brehar F-M, Toader C, Covache-Busuioc R-A, Corlatescu AD, Bordeianu A, et al. Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy. Biomolecules. 2023;13(9):1388.
Wang T, Xia K, Qiu T, Han S, Chen Z, Ma X, et al. A comprehensive survival and prognosis analysis of GPR55 expression in hepatocellular carcinoma. Aging (Albany NY). 2023;15(17):8930.
Wang X, Sun J, Yin X, Zou C, Li H. Effects of behavioral change techniques on diet and physical activity in colorectal cancer patients: a systematic review and meta-analysis. Support Care Cancer. 2023;31(1):29.
Wardill HR, Wooley LT, Bellas OM, Cao K, Cross CB, van Dyk M, et al. Supporting gut health with medicinal cannabis in people with advanced cancer: potential benefits and challenges. Br J Cancer. 2023;130:1–12.
Wood TB, Spivey WN, Easterfield TH III. Cannabinol. Part I J Chem Soc Trans. 1899;75:20–36.
Xiao W, Zheng S, Yang A, Zhang X, Zou Y, Tang H, et al. Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study. Cancer Manag Res. 2018;10:5329–38.
Yanar a, Karolin, Yazıcı Z. Cannabis: Action Mechanisms and Potential Roles in the Management of Type 2 Diabetes Mellitus. Natural Products and their Bioactives in Antidiabetic Drug Discovery. 2023:232-43.
Younes M. The Combination of CBD and THC Isolated from the Lebanese Cannabis sativa Exerts Anti-cancer Effects in Breast Cancer Cells: Lebanese American University. 2023.
Zhang W, Lee AM, Jena S, Huang Y, Ho Y, Tietz KT, et al. Computational drug discovery for castration-resistant prostate cancers through in vitro drug response modeling. Proc Natl Acad Sci. 2023;120(17):e2218522120.
Zhong N, Li D, Wang B, Kovalchuk O, Kovalchuk I. Cannabinol inhibits cell growth and triggers cell cycle arrest and apoptosis in cancer cells. Biocatalysis Agric Biotechnol. 2023;48:102627.
Zuardi AW. História da cannabis como medicamento: uma revisão. Braz J Psychiatry. 2006;28:153–7.
Zupo V, Costantini M, Aflalo ED, Levy T, Chalifa-Caspi V, Obayomi O, et al. Ferroptosis precedes apoptosis to facilitate specific death signalling by fatty acids. Proc R Soc B. 2009;2023(290):20231327.
Discover more from reviewer4you.com
Subscribe to get the latest posts to your email.
